share_log

'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO

'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO

「Theriva 生物製劑已收到美國專利申請津貼通知 16/982,211,標題為「用於治療輻射障礙的鹼性磷酸酶劑」」-USPTO
Benzinga Real-time News ·  2023/01/23 12:07

'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO

「Theriva 生物製劑已收到美國專利申請津貼通知 16/982,211,標題為「用於治療輻射障礙的鹼性磷酸酶劑」」-USPTO

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論